473 related articles for article (PubMed ID: 16466741)
1. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
3. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein.
Panza G; Stöhr J; Dumpitak C; Papathanassiou D; Weiss J; Riesner D; Willbold D; Birkmann E
Biochem Biophys Res Commun; 2008 Sep; 373(4):493-7. PubMed ID: 18585368
[TBL] [Abstract][Full Text] [Related]
5. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
6. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
7. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
8. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
9. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
Wille H; Prusiner SB; Cohen FE
J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
[TBL] [Abstract][Full Text] [Related]
10. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
11. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.
Ricchelli F; Buggio R; Drago D; Salmona M; Forloni G; Negro A; Tognon G; Zatta P
Biochemistry; 2006 May; 45(21):6724-32. PubMed ID: 16716083
[TBL] [Abstract][Full Text] [Related]
12. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
Jones EM; Surewicz WK
Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
[TBL] [Abstract][Full Text] [Related]
13. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
14. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
15. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
16. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
17. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
Ladner-Keay CL; Griffith BJ; Wishart DS
PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
[TBL] [Abstract][Full Text] [Related]
18. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
Inouye H; Kirschner DA
J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
[TBL] [Abstract][Full Text] [Related]
19. Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
Tahiri-Alaoui A; James W
Protein Sci; 2005 Apr; 14(4):942-7. PubMed ID: 15741327
[TBL] [Abstract][Full Text] [Related]
20. Atomic force microscopy to characterize the molecular size of prion protein.
Kunze S; Lemke K; Metze J; Bloukas G; Kotta K; Panagiotidis CH; Sklaviadis T; Bodemer W
J Microsc; 2008 May; 230(Pt 2):224-32. PubMed ID: 18445151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
